Related Experiment Video

Updated: Jul 3, 2026

Biosensor for Detection of Antibiotic Resistant Staphylococcus Bacteria
14:04

Biosensor for Detection of Antibiotic Resistant Staphylococcus Bacteria

Published on: May 8, 2013

[Staphylococcus aureus methicillin-resistance mechanisms]

    Vojnosanitetski Pregled
    |July 17, 2008
    PubMed
    Abstract

    Insights

    Hospital-associated methicillin-resistant Staphylococcus aureus (HA-MRSA) is more prevalent than community-associated MRSA (CA-MRSA). Both HA-MRSA and CA-MRSA show high rates of beta-lactamase production, with no significant difference observed.

    Area of Science:

    • Medical Microbiology
    • Infectious Diseases
    • Antimicrobial Resistance

    Context:

    • Methicillin-resistant Staphylococcus aureus (MRSA) poses a significant global health threat, necessitating effective treatment strategies.
    • Vancomycin is often the empiric choice for severe staphylococcal infections due to widespread MRSA.
    • Understanding resistance mechanisms in both hospital and community settings is crucial for guiding treatment decisions.

    Purpose:

    • To determine beta-lactamase production in hospital-associated MRSA (HA-MRSA) and community-associated MRSA (CA-MRSA) isolates.
    • To assess the prevalence of homogeneous and heterogeneous methicillin resistance, and borderline resistance (BORSA).
    • To identify statistically significant differences in resistance mechanisms between HA-MRSA and CA-MRSA.

    Summary:

    • This study examined 216 hospital and 186 community Staphylococcus aureus isolates.
    • HA-MRSA prevalence was 57.4% compared to 17.7% for CA-MRSA. Heterogeneous resistance was higher in hospital isolates (11.1%) than community isolates (3.8%).
    • Beta-lactamase production was high in both groups (97.5% HA-MRSA, 95.5% CA-MRSA), with similar rates of BORSA (4.6% hospital, 3.3% community).

    Impact:

    • Hospital settings show significantly higher MRSA prevalence and heterogeneous resistance rates.
    • While beta-lactamase production and BORSA were more frequent in hospital isolates, these differences were not statistically significant.
    • Findings highlight the substantial burden of MRSA in hospitals and underscore the need for continued surveillance and infection control measures.

    Related Concept Videos

    Mechanism of Antibiotic Resistance in MRSA01:25

    Mechanism of Antibiotic Resistance in MRSA

    Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
    Clinical Significance of Antibiotic Resistance01:25

    Clinical Significance of Antibiotic Resistance

    Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
    Development of Antibiotic Resistance01:30

    Development of Antibiotic Resistance

    Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
    Staphylococcal Skin Infections01:29

    Staphylococcal Skin Infections

    Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
    Defense Against Bacterial Pathogens01:31

    Defense Against Bacterial Pathogens

    The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
    Phagocytes
    Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
    Inhibitors of Gram-positive Cell Wall Synthesis01:23

    Inhibitors of Gram-positive Cell Wall Synthesis

    Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...